Transient Biocompatible Polymeric Platforms for Long-Term Controlled Release of Therapeutic Proteins and Vaccines.

Materials (Basel) · 2016 · PMC5441878 · PMID 28546855

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may not be significantno p-value reported

However, no significant difference was observed between release rates of IPNFs cross-linked with 0.25 vol % and 0.5 vol % GA suggesting that there may not be significant difference in the cross-linking densities between these IPNFs. 0.25 vol % GA concentration was found to be sufficient for the formation of a cross-linked outer-shell on IPNFs.

also in 2,774 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.